|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Investments at fair value: | ||||||||||||||
| Investment income from non-controlled, non-affiliated investments: | ||||||||||||||
| Non-controlled, affiliated investments | ||||||||||||||
| Investment income from controlled, affiliated investments: | ||||||||||||||
| Level 3 | ||||||||||||||
| Total investments at fair value: | ||||||||||||||
| Cash | ||||||||||||||
| Foreign cash (cost of $236 and $3,923, respectively) | ||||||||||||||
| Interest and dividend receivable | ||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||
| Total Assets | ||||||||||||||
| Liabilities | ||||||||||||||
| Debt (net of deferred unamortized debt issuance costs of $3,018 and $7,791, respectively) | ||||||||||||||
| Payables to affiliates | ||||||||||||||
| Total payables to affiliates | ||||||||||||||
| Distribution payable | ||||||||||||||
| Payable for investments purchased | ||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||
| Total Liabilities | ||||||||||||||
| Net Assets | ||||||||||||||
| Common shares $0.01 par value, 450,000,000 shares authorized; 115,645,897 and 114,946,017 shares issued and outstanding, respectively | ||||||||||||||
| Additional paid-in-capital | ||||||||||||||
| Accumulated undistributed (overdistributed) earnings | ||||||||||||||
| Total Net Assets | ||||||||||||||
| Total Liabilities and Net Assets | ||||||||||||||
| Net Asset Value Per Share (in usd per share) | ||||||||||||||
Loading...
